GL1X · GenesisL1 explorer

MolNFT v1 · #87440 · protein

Crystal structure of the metallo-beta-lactamase imp-1 with L-captopril

4C1F: “Crystal structure of the metallo-beta-lactamase imp-1 with L-captopril”. X-ray diffraction, 3 ligands (X8Z, ZN, SO4), 2 pockets (best druggability 0.78). MolNFT v1 #87440 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
4C1F
Type
protein
Length
436 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase imp-1
EC
3.5.2.6
UniProt
P52699
Ligands
X8Z, ZN, SO4
Pockets
2 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 28% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase imp-1 (EC 3.5.2.6)protein21928% helix, 32% strandP52699
BBeta-lactamase imp-1 (EC 3.5.2.6)protein21727% helix, 30% strandP52699

Ligands and binding sites

  • X8Z · L-captopril · ligand · chains A, B
  • ZN · Zinc ion · metal · 4 copies · chains A, B
  • SO4 · Sulfate ion · ion · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17010.780.8275X8Z
23310.660.8139ZN

Interfaces

1 interface between chains.

  • A–B · 750 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 4C1F · Crystal structure of the metallo-beta-lactamase IMP-1 with L-captopril · the same entry in another collection · chain A against A, TM-score 1.00
  • P52699 · AlphaFold monomer V2.0 prediction for metallo-beta-lactamase type 2 (P52699) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.